Table 1.
Patient characteristics
| Structured training program n = 120 | |
|---|---|
| Sex | |
| Male | 91 (75.8) |
| Female | 29 (24.2) |
| BMI (mean) (± SD) | 26.9 (± 4.0) |
| Age (years) (mean) (± SD) | 65.4 (± 9,9) |
| History of abdominal surgery | |
| No | 91 (75.8) |
| Yes | 29 (24.2) |
| History of transanal surgery | |
| No | 115 (95.8) |
| Yes | 5 (4.2) |
| ASA | |
| I | 25 (21.4) |
| II | 75 (64.1) |
| III | 17 (14.5) |
| Missing data | 3 (2.5) |
| Tumor height (AV) (cm) (mean) (± SD) | 6.9 (± 3.1) |
| Tumor stage | |
| T1 | 6 (5.1) |
| T2 | 23 (19.5) |
| T3 | 87 (73.7) |
| T4 | 2 (1.7) |
| Missing data | 2 (1.7) |
| Mesorectal fascia involvement | |
| No | 97 (82.2) |
| Yes | 21 (17.8) |
| Missing data | 2 (1.7) |
| Preoperative therapy | |
| None | 43 (35.8) |
| RT | 41 (34.2) |
| CRT | 36 (30.0) |
Numbers in parentheses are percentages, unless mentioned otherwise
BMI body mass index (kg/m2), SD standard deviation, ASA American Society of Anesthesiologists, cm centimeters, AV anal verge, RT radiotherapy, CRT chemoradiotherapy